Abstract
Abstract: With multi-drug-resistant tumours continuously evolving, developing new drugs with enhanced efficacy is essential. This study aims to synthesise flavonoid Mannich bases and evaluate their cytotoxic activity. The flavonoids isolated from the leaves of Muntingia calabura were used as reactants for the synthesis. Twenty flavonoid Mannich bases were synthesised via the Mannich reaction. Cytotoxic activity of the parent compounds and synthesised compounds were evaluated against two breast cancer cell lines, i.e., MCF-7, MDA-MB-231, and one normal breast cell line, MCF-10A, via MTT assay. Cytotoxic activity against the MDA-MB-231 cancer cell line showed that flavonoid Mannich bases exhibited greater activity than their parent compounds. 5,7-dihydroxy-8-(4- methoxybenzylamine)-2-phenyl-4H-chromen-4-one (4f) showed the highest cytotoxic activity against MDA-MB-231 cell with IC50 of 5.75±0.82 μM. For the MCF-7 cell line, the parent compounds and Mannich bases showed moderate activity with the IC50 range of 9.17-68.5 μM. For cytotoxic activity against the MCF-10A cell line, the parent compound, 5,7-dihydroxyflavone (4), showed the highest toxicity against MCF-10A with IC50 of 10.55±1.05 μM. The results suggest synthetic modifications have produced compounds with improved anticancer activity and selectivity against breast cancer cells.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.